Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

George Liang King, M.D.

Concepts

This page shows the publications George King has written about Diabetic Retinopathy.
Connection Strength

3.191
  1. Response to Letter to the Editor from Brunerova et al: "Association of Cognitive Function and Retinal Neural and Vascular Structure in Type 1 Diabetes". J Clin Endocrinol Metab. 2021 08 18; 106(9):e3789-e3790.
    View in: PubMed
    Score: 0.510
  2. Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy. Sci Transl Med. 2019 07 03; 11(499).
    View in: PubMed
    Score: 0.440
  3. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care. 2018 04; 41(4):815-822.
    View in: PubMed
    Score: 0.399
  4. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013 Jan 08; 17(1):20-33.
    View in: PubMed
    Score: 0.281
  5. Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes. Invest Ophthalmol Vis Sci. 2012 Dec 19; 53(13):8424-32.
    View in: PubMed
    Score: 0.280
  6. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care. 2011 Apr; 34(4):968-74.
    View in: PubMed
    Score: 0.248
  7. Association of Cognitive Function and Retinal Neural and Vascular Structure in Type 1 Diabetes. J Clin Endocrinol Metab. 2021 03 25; 106(4):1139-1149.
    View in: PubMed
    Score: 0.124
  8. Prevention of diabetes-induced abnormal retinal blood flow by treatment with d-alpha-tocopherol. Biofactors. 1998; 7(1-2):55-67.
    View in: PubMed
    Score: 0.099
  9. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci. 1996 Nov; 37(12):2504-18.
    View in: PubMed
    Score: 0.091
  10. Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes. Diabetes Care. 2014 Aug; 37(8):2193-201.
    View in: PubMed
    Score: 0.077
  11. Evaluating retinal circulation using video fluorescein angiography in control and diabetic rats. Curr Eye Res. 1992 Apr; 11(4):287-95.
    View in: PubMed
    Score: 0.067
  12. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A. 2008 May 13; 105(19):6998-7003.
    View in: PubMed
    Score: 0.051
  13. Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care. 2007 Aug; 30(8):1995-7.
    View in: PubMed
    Score: 0.047
  14. Hyperglycemia and the pathogenesis of diabetic retinopathy. J Gen Intern Med. 1986 Mar-Apr; 1(2):133-4.
    View in: PubMed
    Score: 0.044
  15. Cell biology as an approach to the study of the vascular complications of diabetes. Metabolism. 1985 Dec; 34(12 Suppl 1):17-22.
    View in: PubMed
    Score: 0.043
  16. Microvascular complications of diabetes. Endocrinol Metab Clin North Am. 2004 Mar; 33(1):215-38, xi-xii.
    View in: PubMed
    Score: 0.038
  17. Retinopathy in diabetes. Diabetes Care. 2004 Jan; 27 Suppl 1:S84-7.
    View in: PubMed
    Score: 0.038
  18. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest. 2003 Jun; 111(12):1835-42.
    View in: PubMed
    Score: 0.036
  19. Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. Diabetes. 2003 Mar; 52(3):838-45.
    View in: PubMed
    Score: 0.035
  20. Diabetic retinopathy. Diabetes Care. 2003 Jan; 26 Suppl 1:S99-S102.
    View in: PubMed
    Score: 0.035
  21. Diabetic retinopathy. Diabetes Care. 2003 Jan; 26(1):226-9.
    View in: PubMed
    Score: 0.035
  22. von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care. 2000 Nov; 23(11):1694-8.
    View in: PubMed
    Score: 0.030
  23. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care. 1999 Aug; 22(8):1245-51.
    View in: PubMed
    Score: 0.028
  24. Diabetic retinopathy. Diabetes Care. 1998 Jan; 21(1):143-56.
    View in: PubMed
    Score: 0.025
  25. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab. 2017 12 01; 102(12):4343-4410.
    View in: PubMed
    Score: 0.025
  26. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes. 1995 Jan; 44(1):98-103.
    View in: PubMed
    Score: 0.020
  27. Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med. 1994; 45:179-88.
    View in: PubMed
    Score: 0.019
  28. Insulin receptor substrate 2 is essential for maturation and survival of photoreceptor cells. J Neurosci. 2005 Feb 02; 25(5):1240-8.
    View in: PubMed
    Score: 0.010
  29. Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels. J Clin Invest. 1983 Apr; 71(4):974-9.
    View in: PubMed
    Score: 0.009
  30. Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes. 2003 Mar; 52(3):829-37.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.